Delek US (NYSE:DK) Price Target Raised to $44.00

Delek US (NYSE:DK) had its price objective upped by TD Cowen from $28.00 to $44.00 in a research report sent to investors on Thursday, MarketBeat.com reports. The brokerage currently has a hold rating on the oil and gas company’s stock.

DK has been the subject of a number of other research reports. Mizuho increased their target price on Delek US from $45.00 to $51.00 and gave the stock an “outperform” rating in a report on Friday, December 12th. Wells Fargo & Company upped their price objective on Delek US from $43.00 to $53.00 and gave the stock an “overweight” rating in a research report on Monday, November 10th. JPMorgan Chase & Co. decreased their price objective on Delek US from $42.00 to $38.00 and set a “neutral” rating for the company in a report on Thursday, January 15th. Citigroup cut their target price on Delek US from $37.00 to $33.00 and set a “neutral” rating on the stock in a research note on Monday, January 26th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Delek US in a research report on Wednesday, January 21st. Four investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $39.46.

Delek US Stock Performance

Shares of DK opened at $42.35 on Thursday. The firm has a market cap of $2.54 billion, a P/E ratio of -121.00 and a beta of 0.75. Delek US has a twelve month low of $11.02 and a twelve month high of $45.74. The company has a debt-to-equity ratio of 5.89, a quick ratio of 0.58 and a current ratio of 0.82. The firm’s 50 day moving average price is $32.38 and its two-hundred day moving average price is $33.38.

Delek US (NYSE:DK) last issued its quarterly earnings data on Friday, February 27th. The oil and gas company reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.19) by $0.63. The company had revenue of $2.43 billion during the quarter, compared to the consensus estimate of $2.55 billion. Delek US had a negative net margin of 0.21% and a negative return on equity of 13.55%. The firm’s revenue was up 2.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($2.54) earnings per share. On average, analysts forecast that Delek US will post -5.5 EPS for the current fiscal year.

Delek US Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 9th. Investors of record on Monday, March 2nd will be given a dividend of $0.255 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $1.02 annualized dividend and a yield of 2.4%. Delek US’s dividend payout ratio is -291.43%.

Insider Transactions at Delek US

In other news, Director Shlomo Zohar sold 22,029 shares of the stock in a transaction that occurred on Thursday, March 5th. The stock was sold at an average price of $44.83, for a total value of $987,560.07. Following the completion of the sale, the director owned 18,989 shares of the company’s stock, valued at approximately $851,276.87. This represents a 53.71% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Joseph Israel sold 38,000 shares of the firm’s stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $40.65, for a total transaction of $1,544,700.00. Following the completion of the transaction, the executive vice president directly owned 55,623 shares of the company’s stock, valued at $2,261,074.95. This represents a 40.59% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 142,764 shares of company stock valued at $5,989,317. 1.80% of the stock is owned by insiders.

Institutional Trading of Delek US

A number of large investors have recently added to or reduced their stakes in DK. Royal Bank of Canada grew its position in shares of Delek US by 18.4% in the 1st quarter. Royal Bank of Canada now owns 278,774 shares of the oil and gas company’s stock valued at $4,201,000 after acquiring an additional 43,379 shares during the period. AQR Capital Management LLC acquired a new stake in Delek US in the 1st quarter valued at about $390,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Delek US by 3.1% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 37,190 shares of the oil and gas company’s stock worth $560,000 after purchasing an additional 1,102 shares during the period. Jones Financial Companies Lllp increased its position in Delek US by 3,979.8% during the first quarter. Jones Financial Companies Lllp now owns 20,399 shares of the oil and gas company’s stock worth $307,000 after buying an additional 19,899 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Delek US by 7.2% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,871 shares of the oil and gas company’s stock valued at $2,213,000 after buying an additional 9,827 shares during the period. Institutional investors and hedge funds own 97.01% of the company’s stock.

Delek US News Roundup

Here are the key news stories impacting Delek US this week:

• Positive Sentiment: TD Cowen raised its price target from $28 to $44 (hold), narrowing upside uncertainty and signaling improving analyst visibility. Finviz
• Positive Sentiment: Quarterly results: Delek US reported a surprise EPS beat ($0.44 vs. est. -$0.19), which is supportive for the shares despite a slight revenue shortfall. (Source: company/market coverage)
• Positive Sentiment: Dividend declared: a $0.255 quarterly dividend (annualized $1.02, ~2.3% yield) payable March 9 — offers short-term income support for the stock.
• Neutral Sentiment: Institutional activity: several large funds have adjusted positions recently (mix of increases and new stakes); institutional ownership remains high (~97%), which can both stabilize and concentrate stock moves.
• Negative Sentiment: CEO sale: CEO Avigal Soreq sold 50,000 shares (~$2.05M at ~$41.08). Large insider sales from the CEO often trigger investor concern about timing and outlook. CEO Sale — SEC filing: Form 4
• Negative Sentiment: Additional insider selling: multiple executives and directors sold sizable stakes in early March (EVPs Reuven Spiegel — 20,000 sh; Joseph Israel — 38,000 sh; Directors Shlomo Zohar and William Finnerty also sold). The cluster of senior-level sales is adding downward pressure. Relevant SEC filings: Spiegel (Read More.), Israel (Read More.), Zohar (Read More.), Finnerty (Read More.).
• Negative Sentiment: Analyst moves mixed-to-negative: Citi and Piper Sandler trimmed price targets (to $33 and $40 respectively) and Weiss reiterated a sell — these downward revisions amplify selling pressure even as some shops (e.g., Mizuho) remain bullish.

Delek US Company Profile

Delek US Holdings, Inc (NYSE: DK) is an independent downstream energy company engaged in the refining, logistics, and marketing of petroleum products. Headquartered in Brentwood, Tennessee, the company operates a network of inland refineries, storage terminals and pipelines, and convenience store locations. Delek US focuses on converting crude oil into a variety of finished products, including gasoline, diesel, jet fuel, asphalt and renewable fuels, serving wholesale and retail customers across the United States.

In its refining segment, Delek US owns and operates four inland refineries located in Texas and Arkansas.